Research graph
References from Validation of the Proposed cN2 Subclassification in the Eighth Edition of the IASLC Staging System: A Prospective Phase II Multicenter Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 · External reference
Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system
10.1002/cncr.29045 · 2014 · External reference
Demographics, safety and quality, and prognostic information in both the seventh and eighth editions of the TNM classification in 18,973 surgical cases of the Japanese Joint Committee of Lung Cancer Registry database in 2010
10.1016/j.jtho.2018.10.002 · 2019 · External reference
NCCN guidelines insights: non-small cell lung cancer, Version 1.2020
10.6004/jnccn.2019.0059 · 2019 · External reference
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdx222 · 2017 · External reference
Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer
10.1016/j.athoracsur.2008.04.042 · 2008 · External reference
The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer
10.1016/j.jtho.2015.09.009 · 2016 · External reference
Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping
10.2214/ajr.144.2.261 · 1985 · External reference
Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography
10.1016/s0022-5223(96)70317-3 · 1996 · External reference
Prognosis in N2 NSCLC
10.1016/j.lungcan.2004.07.993 · 2004 · External reference
Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer
10.1016/j.ejcts.2008.03.060 · 2008 · External reference
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer
10.1200/jco.1999.17.9.2692 · 1999 · External reference
Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study
10.1016/j.lungcan.2005.05.021 · 2005 · External reference
A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung
10.1056/nejmoa032792 · 2004 · External reference
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer
10.1097/jto.0000000000000678 · 2015 · External reference
The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer
10.1097/jto.0000000000000334 · 2014 · External reference
Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade
10.1097/jto.0b013e318219aae2 · 2011 · External reference
Surgical outcome of stage IIIA-cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004
10.1097/jto.0b013e31824c945b · 2012 · External reference
A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
10.1056/nejm199401203300301 · 1994 · External reference
Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
10.1016/s0140-6736(13)62159-5 · 2014 · External reference
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
10.1056/nejmoa031644 · 2004 · External reference
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
10.1200/jco.2007.13.9030 · 2008 · External reference
Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the lung adjuvant cisplatin evaluation
10.1097/jto.0b013e3181c814e7 · 2010 · External reference
Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials
10.1097/jto.0b013e3181b9ecca · 2009 · External reference
Now or later: evaluating the importance of chemotherapy timing in resectable stage III (N2) lung cancer in the National Cancer Database
10.1016/j.athoracsur.2014.08.040 · 2015 · External reference
Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC
10.1056/nejmoa1809697 · 2018 · External reference
Three-year overall survival with durvalumab after chemoradiotherapy in stage III NSCLC—update from PACIFIC
10.1016/j.jtho.2019.10.002 · 2020 · External reference
Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)
10.1378/chest.07-1379 · 2007 · External reference
2nd ESMO Consensus Conference in lung cancer: locally advanced stage III non-small-cell lung cancer
10.1093/annonc/mdv187 · 2015 · External reference
Multimodality therapy in subclassified stage IIIA-N2 non-small cell lung cancer patients according to the Robinson classification: heterogeneity and management
10.21037/jtd.2018.05.203 · 2018 · External reference
Resectable clinical N2 non-small cell lung cancer; what is the optimal treatment strategy? An update by the British Thoracic Society Lung Cancer Specialist Advisory Group
10.1016/j.jtho.2017.05.023 · 2017 · External reference
Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
10.1016/j.lungcan.2004.01.017 · 2004 · External reference
The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer
10.1016/j.athoracsur.2008.07.076 · 2008 · External reference
Recommended change in the N descriptor proposed by the International Association for the Study of Lung Cancer: a validation study
10.1016/j.jtho.2019.07.034 · 2019 · External reference
